Please use this identifier to cite or link to this item:
Title: Efficacy and cost of video-assisted thoracoscopic partial pleurectomy versus talc pleurodesis in patients with malignant pleural mesothelioma (MesoVATS): An open-label, randomised, controlled trial
Authors: Rintoul, RC
Ritchie, AJ
Edwards, JG
Waller, DA
Coonar, AS
Bennett, M
Lovato, E
Hughes, V
Fox-Rushby, JA
Sharples, LD
Keywords: Malignant pleural mesothelioma incidence;Video-assisted thoracoscopic partial pleurectomy (VAT-PP);Symptom control
Issue Date: 2014
Publisher: Lancet Publishing Group
Citation: The Lancet, 383, pp. 1118 - 1127, 2014
Abstract: Background: Malignant pleural mesothelioma incidence continues to rise, with few available evidence-based therapeutic options. Results of previous non-randomised studies suggested that video-assisted thoracoscopic partial pleurectomy (VAT-PP) might improve symptom control and survival. We aimed to compare efficacy in terms of overall survival, and cost, of VAT-PP and talc pleurodesis in patients with malignant pleural mesothelioma.
ISSN: 0140-6736
Appears in Collections:Health Economics Research Group (HERG)

Files in This Item:
File Description SizeFormat 
Fulltext.pdf624.24 kBAdobe PDFView/Open

Items in BURA are protected by copyright, with all rights reserved, unless otherwise indicated.